Hold control (command on a Mac) and press the + key as many times as necessary to increase the font size.
Hold control (command on a Mac) and press the - key to reduce the font size. - hide

Beta Blockers in Graves' Disease



by Chalet A. DeCapito, PharmD; Timothy W. Lowrey, PharmD; and William J. Millard, Ph.D.

Inderal® (propranolol), a beta (β)-adrenergic blocking agent, is often used in patients with Graves’ disease. Such therapy is thought to result in more rapid relief of some of the signs and symptoms, but it has no effect on the fundamental disease. Presented below is an overview of β-adrenergic blocking agents, more commonly called β-blockers, in relation to the patient with Graves’ disease.

Mechanism

These medicines belong to a class of drugs called “β-blockers” because they block specific components of tissues called β-receptors and prevent adrenaline and other similar compounds from having an effect on different parts of the body. Graves’ disease patients have increased sensitivity to adrenaline, and along with increased thyroid hormone in their blood, this results in rapid heart beat, sweating, shakiness, anxiety, increased appetite, loss of weight, and intolerance to heat. β-blockers help to alleviate these symptoms when given along with antithyroid drugs or radioactive iodine in an effort to make the patient more comfortable while awaiting return to normal thyroid function. It should be pointed out that propranolol and other β-blockers do not have important antithyroid effects. However, they can cause a slight decrease in the conversion of the major thyroid hormone, thyroxine (T4) to its biologically active form triiodothyronine (T3).

Use or Indication

1. Thyroid storm.

2. Additive to treatment with radioactive iodine; β-blockers can be used to control symptoms for the 4-8 weeks between the administration of radioactive iodine and its subsequent effects.

3. Preparation of patients for surgical removal of the thyroid gland when antithyroid drugs cannot be used (allergies to the antithyroid drugs).

4. To slow rapid heartbeat.

Contraindications

Propranolol and other β-blockers should be used with great caution in patients with the following conditions:

1. Lung diseases such as emphysema and asthma, because these agents cause bronchioconstriction (narrowing of air passages in the lung).

2. Heart failure, unless secondary to hyperthyroidism.

Side Effects

Most people experience few or no side effects from this class of medications. However, any drug can sometimes cause unwanted effects. It is important to call your doctor if you develop a skin rash, shortness of breath, fever, wheezing, unusual bleeding or bruising, swelling of legs or ankles, sudden weight gain, impotence or decreased sexual ability, changes in vision, cold hands or feet, and numbness or tingling of the fingers or toes. Also, call your doctor if you develop nightmares, symptoms of depression, insomnia, unusual tiredness, headaches, or if you become confused.

Interactions

Patients with Graves’ disease are usually taking a variety of medications along with a β-blocker. Many of these medications can interact with each other producing unwanted side effects. It is very important in the course of developing a patient’s therapeutic drug regimen, that all additional drugs be thoroughly discussed with their doctor or pharmacist to provide the best treatment results. Outlined below is a short list of drugs which may interact adversely with β-blockers (this is not inclusive of all interactions that exist with β-blockers): oral anti-diabetics (e.g. Glucotrol® or Diabeta®) and insulin, β-agonists (e.g. Ventolin®), all narcotics, non-steroidal antiinflammatory drugs (e.g. Motrin ®), anti-convulsants (e.g. Dilantin ®), theophylline, antiarrhythmic agents such as quinidine (e.g. Quinora® or Quinaglute®), and antihypertensive agents.

Dosage Regimen An oral dose of 40-160 mg as a single or divided dose of propranolol (Inderal®) given daily for a period of several weeks to months helps to achieve symptomatic relief in most patients. Newer and longer acting β-blockers are equally effective in equivalent doses including atenolol (Tenormin®), nadolol (Corgard®), or metoprolol (Lopressor®).

Summary As the activity of the thyroid declines from specific thyroid drug therapy, the dose of the β-blocker may be reduced and finally stopped. It is important to note that ??blockers do not alter all the effects of excess thyroid activity, and in some patients may have no beneficial effects when given simultaneously with antithyroid drugs. Also, β-blockers can have some adverse effects, particularly in hyperthyroid patients with cardiac disease. Therefore, β-blockers are valuable in patients with Graves’ disease, but their main role is to enhance or support ongoing drug therapy of the disease.

Used with the permission of the authors:

Chalet A. DeCapito, PharmD; Timothy W. Lowrey, PharmD; and William J. Millard, PhD., Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610 ©1992

Download as a PDF.

Recent News

Recent Forum Posts

  • GD with TED

    May 27, 2017, 5:12 p.m.

    klassey, Sure glad to hear things are going in the right direction. From the onset I was anxious to get the...

  • Orbital Decompression

    May 27, 2017, 4:59 p.m.

    tajkoont, I was really worried about getting orbital decompression done. Once my Graves had burned out I had...

  • Login Issues? Try Clearing Your Browser History and Restart

    May 26, 2017, 6:18 p.m.

    bump bump bump

  • Orbital Decompression

    May 26, 2017, 4:25 p.m.

    tajkoont Kimberly - How long have you been off of the methimazole? I am assuming you are in remission? Hello...

  • Symptoms lag behind tsh and Free T4

    May 25, 2017, 9:37 p.m.

  • GD with TED

    May 25, 2017, 11:58 a.m.

    Thank you, I just posted an update on May 23rd, I'm getting excited !!! Klassey

  • Orbital Decompression

    May 24, 2017, 2:43 p.m.

    I'll just throw my oar in here in case it helps. I have had bilateral OD, and was taking methimazole when I...

  • Orbital Decompression

    May 24, 2017, 1:25 p.m.

    Kimberly - How long have you been off of the methimazole? I am assuming you are in remission?

  • Orbital Decompression

    May 24, 2017, 1:23 p.m.

    Thank you both. Dr. Douglas is great. I just skyped with him. He told me ultimately I will need to have the...

  • GD with TED

    May 23, 2017, 5:47 p.m.

    Update, Saw my eye Dr and he is pleased with my numbers upon measuring my eyes. I have more movement from...

  • Orbital Decompression

    May 23, 2017, 3:45 p.m.

    Dr Douglas did my decompressions. My first experience with general anesthesia was my thyroidectomy. That...

  • Orbital Decompression

    May 23, 2017, 2:40 p.m.

    Hello - Hopefully, Liz1967 will chime in here. I can tell you that I had a surgery (unrelated to Graves')...

  • Orbital Decompression

    May 23, 2017, 7:22 a.m.

    I wanted to update you. I have a consultation with Dr. Douglas tomorrow at 4:00. I also got to read my CT...

  • Tests Are Normal but I Don't Feel It

    May 22, 2017, 3:47 p.m.

    Hello - Hopefully, you have a copy of your lab results so that you can check the reference range for...

  • Login Issues? Try Clearing Your Browser History and Restart

    May 22, 2017, 3:43 p.m.

    bumping…again…

Questions? Problems? Please contact us at info@ngdf.org or 877-643-3123.

GDATF on Facebook

Support the GDATF and become a member today!

© 2017 Graves' Disease & Thyroid Foundation